Table 3.
Incidence Rate of Being Lost to Follow-Up and Mortality of Children and Adolescents Initiating Antiretroviral Therapy in Central Kenya (2004–2014).
| Time (months) | pyo | No. of events (n) | Rate per 100 pyo (95% CI) | Cumulative incidence (%)a |
|---|---|---|---|---|
| LTFU outcome | ||||
| 6 months | 2,435.25 | 305 | 12.52 (11.19–14.01) | 5.0 |
| 12 months | 2,284.17 | 275 | 12.04 (10.70–13.55) | 9.9 |
| 24 months | 4,019.33 | 692 | 17.22 (15.98–18.55) | 22.9 |
| 36 months | 3,414.5 | 509 | 14.91 (13.67–16.26) | 33.1 |
| Total | 12,153.25 | 1,781 | 14.65 (13.99–15.35) | 33.1 |
| Mortality Outcome | ||||
| 6 months | 2,435.25 | 51 | 2.09 (1.59–2.76) | 0.7 |
| 12 months | 2,284.17 | 16 | 0.70 (0.43–1.14) | 1.0 |
| 24 months | 4,019.33 | 14 | 0.35 (0.21–0.59) | 1.2 |
| 36 months | 3,414.5 | 24 | 0.70 (0.47–1.05) | 1.5 |
| Total | 12,153.25 | 105 | 0.86 (0.71–1.05) | 1.5 |
a
Estimated based on the cumulative incidence function of the multivariable regression model.
CI, confidence interval; pyo, person years of observation.